LLY — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Eli Lilly and Company
Healthcare · $1133
1.0
/10
Poor Entry
Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
Surface indicators and our internal signals diverge — the score reflects the combined read.
How this score works → Try the calculator ↓
Regime
Bullish
vs SMA200
SMA200 Distance
+18.2%
Above trend
Volatility
Normal
Average premiums
Momentum
Positive
was Accelerating
About Eli Lilly and Company
Eli Lilly manufactures GLP-1 drugs Mounjaro and Zepbound for diabetes and obesity, driving explosive revenue growth. Beta ~0.50, tiny ~0.7% yield — trades like a growth stock with a high nominal share price. Wide premium swings around FDA events and earnings; attractive but risky for put sellers.
Pharmaceuticals — Major
Market Cap
$1.0T
P/E Ratio
40.3
Dividend
0.61%
Beta
0.52
52-Week Range Current: $1133
$623.78 $1182.73
Earnings
2026-08-05
53 days away
Price Action
Bearish Engulfing
Bearish warning pattern detected on recent candles

LLY — the trend is intact, but at the 91st percentile of its 52-week range, less structural buffer remains between current price and recent support than the trend itself suggests.

Based on end-of-day market dataScored by ThetaLoop Research
LLY ranks #30 of 66 Healthcare tickers by put-selling score (622 total screened)

Position Size & Yield Calculator

Live model for LLY — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
APT Alpha Pro Tech, Ltd. 7.9 SMMT Summit Therapeutics Inc. 6.9 BMY Bristol-Myers Squibb Company 6.8 NVAX Novavax, Inc. 5.6 SRPT Sarepta Therapeutics, Inc. 4.9 Browse all Healthcare tickers →
📌 Embed this score on your blog
The LLY X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/LLY" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/LLY">LLY X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Full Research Track Record — All Wins AND Losses
Cash-Secured Puts ↗ · See a sample →